Top Markets
#1 Akedo Akedo +59.38%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.41%
#4 Velvet Velvet +39.92%
#5 Black Phoenix Black Phoenix +34.56%
#6 Ο„emplar Ο„emplar +23.53%
#7 Ribbita by Virtuals Ribbita by Virtuals +17.77%
#8 Cross Cross +15.77%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.57%
#10 Bitway Bitway +15.46%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rank in Stocks #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Share Price
$1.51
Last synced: 2024-08-26
Market Cap
$1.12M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Agile Therapeutics, Inc. (AGRX)

Category

Healthcare
Number of shares outstanding for Agile Therapeutics, Inc. (AGRX)
Number of shares outstanding as of June 2024: 6.86M
According to Agile Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 6.86M. At the end of December 2022 the company had 432.22K shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Agile Therapeutics, Inc. (AGRX) from 2012 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 6.86M 217.90%
2023 2.16M 398.99%
2022 432.22K 35,520.10%
2021 1.21K -97.13%
2020 42.34K 71.31%
2019 24.72K 44.06%
2018 17.16K 10.90%
2017 15.47K 9.44%
2016 14.14K 28.42%
2015 11.01K 93.22%
2014 5.70K 26.21%
2013 4.51K 0.00%
2012 4.51K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 34,894.97%
IN